Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05199285
Title Nivolumab and Ipilimumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Liver Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications

Advanced Solid Tumor

Therapies

Ipilimumab + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama- Birmingham Birmingham Alabama 35233 United States Details
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field